Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus

Improving Care for Children With ADHD: The Information is Just a Rating Scale Away

(2016) William J. Barbaresi   PEDIATRICS

Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice

(2015) Jane J. Kim et al.   ANNALS OF INTERNAL MEDICINE

Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance

(2015) Warner K. Huh et al.   GYNECOLOGIC ONCOLOGY

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

(2015) Aimée R Kreimer et al.   LANCET ONCOLOGY

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

(2015) Elmar A. Joura et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012

(2015) Susan Hariri et al.   VACCINE

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014

(2015) Sarah Reagan-Steiner et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

An Updated Natural History Model of Cervical Cancer: Derivation of Model Parameters

(2014) Nicole G. Campos et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Human Papillomavirus Genotype-Specific Prevalence across the Continuum of Cervical Neoplasia and Cancer

(2014) N. E. Joste et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

(2014) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine

(2014) Paulo S Naud et al.   Human Vaccines & Immunotherapeutics

Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

How distressing is referral to colposcopy in cervical cancer screening?

(2013) Ida J. Korfage et al.   GYNECOLOGIC ONCOLOGY

Population Impact of HPV Vaccines: Summary of Early Evidence

(2013) Susan Hariri et al.   JOURNAL OF ADOLESCENT HEALTH

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

(2013) L. Stewart Massad et al.   Journal of Lower Genital Tract Disease

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

(2012) Debbie Saslow et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A population-based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination

(2012) Cosette M. Wheeler et al.   INTERNATIONAL JOURNAL OF CANCER

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

(2011) Aimée R. Kreimer et al.   JNCI-Journal of the National Cancer Institute

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

(2011) Julia ML Brotherton et al.   LANCET

Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection

(2010) A. C. Rodriguez et al.   JNCI-Journal of the National Cancer Institute

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination

(2008) J. D. Goldhaber-Fiebert et al.   JNCI-Journal of the National Cancer Institute

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

(2008) Rolando Herrero et al.   VACCINE